Interviews

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.

Mark Parkinson, CEO of the American Health Care Association, discusses how the roles and responsibilities of pharmacists might evolve in response to recent changes within the past-acute care industry.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the rewards and challenges of treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the drugs that should be used cautiously when treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the recent changes made to the American Geriatrics Society Beers Criteria.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the potential complications that can arise from improper renal dosing.